- Home
- PRPH vs CLRB Comparison
PRPH vs CLRB Comparison
Compare PRPH & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPH
- CLRB
- Stock Information
- Founded
- PRPH 1989
- CLRB 2002
- Country
- PRPH United States
- CLRB United States
- Employees
- PRPH N/A
- CLRB N/A
- Industry
- PRPH Biotechnology: Pharmaceutical Preparations
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- PRPH Health Care
- CLRB Health Care
- Exchange
- PRPH Nasdaq
- CLRB Nasdaq
- Market Cap
- PRPH 17.9M
- CLRB 17.5M
- IPO Year
- PRPH 1997
- CLRB N/A
- Fundamental
- Price
- PRPH N/A
- CLRB $4.78
- Analyst Decision
- PRPH
- CLRB Hold
- Analyst Count
- PRPH 0
- CLRB 2
- Target Price
- PRPH N/A
- CLRB N/A
- AVG Volume (30 Days)
- PRPH 2.4M
- CLRB 109.6K
- Earning Date
- PRPH 11-12-2025
- CLRB 11-17-2025
- Dividend Yield
- PRPH N/A
- CLRB N/A
- EPS Growth
- PRPH N/A
- CLRB N/A
- EPS
- PRPH N/A
- CLRB N/A
- Revenue
- PRPH $5,588,000.00
- CLRB N/A
- Revenue This Year
- PRPH $221.82
- CLRB N/A
- Revenue Next Year
- PRPH N/A
- CLRB N/A
- P/E Ratio
- PRPH N/A
- CLRB N/A
- Revenue Growth
- PRPH N/A
- CLRB N/A
- 52 Week Low
- PRPH $0.22
- CLRB $4.11
- 52 Week High
- PRPH $2.50
- CLRB $66.00
- Technical
- Relative Strength Index (RSI)
- PRPH 78.99
- CLRB 43.33
- Support Level
- PRPH $0.40
- CLRB $4.95
- Resistance Level
- PRPH $0.67
- CLRB $6.52
- Average True Range (ATR)
- PRPH 0.05
- CLRB 0.40
- MACD
- PRPH 0.02
- CLRB -0.04
- Stochastic Oscillator
- PRPH 78.72
- CLRB 3.82
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.